We are live on ! Find out more
AIM

Advantage Investment Management Portfolio holdings

AUM $128M
1-Year Est. Return 0.94%
This Fund
S&P 500
This Quarter Est. Return
+3.56%
1 Year Est. Return
+0.94%
3 Year Est. Return
+28.59%
5 Year Est. Return
+40.78%
10 Year Est. Return
–
AUM
$307M
AUM Growth
+$20.4M
Cap. Flow
+$11.1M
Cap. Flow %
3.61%
Top 10 Hldgs %
29.82%
Holding
1,175
New
79
Increased
283
Reduced
241
Closed
135

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$12.8M
2
USMV icon
iShares MSCI USA Min Vol Factor ETF
USMV
+$10.9M
3
IYR icon
iShares US Real Estate ETF
IYR
+$7M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$6.66M
5
IYH icon
iShares US Healthcare ETF
IYH
+$3.28M

Top Sells

Rank Stock Value
1
FVD icon
First Trust Value Line Dividend Fund
FVD
+$10.7M
2
FTCS icon
First Trust Capital Strength ETF
FTCS
+$8.36M
3
RSP icon
Invesco S&P 500 Equal Weight ETF
RSP
+$4.07M
4
HYD icon
VanEck High Yield Muni ETF
HYD
+$4.05M
5
QUAL icon
iShares MSCI USA Quality Factor ETF
QUAL
+$3.88M

Sector Composition

Rank Sector Weight
1 Financials 7.41%
2 Technology 4.46%
3 Communication Services 3.37%
4 Healthcare 3.28%
5 Industrials 3.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SCMP
876
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$4K ﹤0.01%
311
– –
UN
877
DELISTED
Unilever NV New York Registry Shares
UN
$4K ﹤0.01%
+61
New +$3.56K
ADM icon
878
Archer Daniels Midland
ADM
$37.4B
$3K ﹤0.01%
66
– –
AMT icon
879
American Tower
AMT
$78.3B
$3K ﹤0.01%
19
+7
+58% +$974
ANIP icon
880
ANI Pharmaceuticals
ANIP
$1.82B
$3K ﹤0.01%
62
– –
ARGT icon
881
Global X MSCI Argentina ETF
ARGT
$836M
$3K ﹤0.01%
81
-91
-53% -$2.72K
ATHE
882
Alterity Therapeutics
ATHE
$79.2M
$3K ﹤0.01%
112
– –
AZN icon
883
AstraZeneca
AZN
$250B
$3K ﹤0.01%
50
– –
BCRX icon
884
BioCryst Pharmaceuticals
BCRX
$2.31B
$3K ﹤0.01%
560
– –
CBRL icon
885
Cracker Barrel
CBRL
$1.31B
$3K ﹤0.01%
21
– –
CHRW icon
886
C.H. Robinson
CHRW
$17.9B
$3K ﹤0.01%
41
-32
-44% -$2.22K
CSL icon
887
Carlisle Companies
CSL
$15.3B
$3K ﹤0.01%
31
– –
DKS icon
888
Dick's Sporting Goods
DKS
$17.9B
$3K ﹤0.01%
99
– –
DOC icon
889
Healthpeak Properties
DOC
$15B
$3K ﹤0.01%
106
+1
+1% +$30
EIRL icon
890
iShares MSCI Ireland ETF
EIRL
$77.1M
$3K ﹤0.01%
66
– –
ENZL icon
891
iShares MSCI New Zealand ETF
ENZL
$83.6M
$3K ﹤0.01%
63
– –
EPHE icon
892
iShares MSCI Philippines ETF
EPHE
$145M
$3K ﹤0.01%
84
– –
ETR icon
893
Entergy
ETR
$49.9B
$3K ﹤0.01%
+90
New +$3.48K
FBIN icon
894
Fortune Brands Innovations
FBIN
$6.24B
$3K ﹤0.01%
+59
New +$3.27K
FTA icon
895
First Trust Large Cap Value AlphaDEX Fund
FTA
$1.4B
$3K ﹤0.01%
62
– –
HYEM icon
896
VanEck Emerging Markets High Yield Bond ETF
HYEM
$522M
$3K ﹤0.01%
+133
New +$3.27K
OPLN
897
Openlane
OPLN
$4.05B
$3K ﹤0.01%
+180
New +$2.97K
LH icon
898
Labcorp
LH
$25.4B
$3K ﹤0.01%
23
– –
LPX icon
899
Louisiana-Pacific
LPX
$5.4B
$3K ﹤0.01%
98
– –
MRSH
900
Marsh
MRSH
$91.4B
$3K ﹤0.01%
+41
New +$3.25K
34 35
36
37 38

Similar funds

SAM
Shamrock Asset Management Dallas, Texas $128M AUM 2.65% 1-Year Est. Return
MHIM
MacNealy Hoover Investment Management Canton, Ohio $124M AUM 4.7% 1-Year Est. Return
MF
Madrona Funds Everett, Washington $136M AUM
WPSG
Wealth & Pension Services Group Atlanta, Georgia $138M AUM 1.38% 1-Year Est. Return
AGPM
ASA Gold & Precious Metals Portland, Maine $117M AUM 43.53% 1-Year Est. Return
NCM
Northstar Capital Management New York $112M AUM 2.1% 1-Year Est. Return
WAM
Warlander Asset Management New York $111M AUM 8.26% 1-Year Est. Return
GPC
Glacier Peak Capital Bellevue, Washington $96.2M AUM 0.45% 1-Year Est. Return

Advantage Investment Management's Q3 2017 Portfolio in Review

As of Q3 2017, Advantage Investment Management held 1,175 positions worth $307M, up 7.1% from $286M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Advantage Investment Management deployed $11.1M of net new capital in Q3 2017, opening 79 new positions and adding to 283 existing holdings. Its largest new stake was iShares Russell Top 200 Growth ETF: 24,219 shares worth $1.64M.

By sector, the portfolio is most concentrated in Financials at 7.4% of assets, down from 7.5% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was First Trust Value Line Dividend Fund, an estimated $10.7M trimmed.

  • Advantage Investment Management's largest Q3 2017 buy was iShares Russell Top 200 Growth ETF: 24,219 shares worth $1.64M.
  • Advantage Investment Management added most to iShares Core S&P 500 ETF in Q3 2017, an estimated $12.8M increase.
  • Advantage Investment Management's biggest Q3 2017 reduction was First Trust Value Line Dividend Fund, cutting an estimated $10.7M.
  • Advantage Investment Management fully exited State Street SPDR Portfolio Intermediate Term Corporate Bond ETF in Q3 2017, selling an estimated $1.27M.
  • Advantage Investment Management's ten largest holdings make up 30% of its $307M portfolio in Q3 2017.
  • Advantage Investment Management opened 79 new positions and closed 135 in Q3 2017.
  • Advantage Investment Management's portfolio value rose 7.1% quarter-over-quarter to $307M.

Based on Advantage Investment Management's 13F filing for Q3 2017, filed 13 Nov 2017.